Revealing Kissinger s 100 year old secret!An important detail behind the longevity of the rich is hi

Mondo Health Updated on 2024-01-30

Revealing Kissinger's 100-year-old secret!An important detail behind the longevity of the rich is hidden by Harvard

The news of Mr. Kissinger's recent farewell to this world shook the entire international community. Only five months ago, Kissinger, the 100-year-old birthday boy, came to China from afar, and even after a long journey, he was still in good spirits and in good health, not at all like an elderly man who had already turned 100 years old.

Kissinger's son, David, revealed that his father was not particularly keen on sports, enjoyed fried food, and was a tireless workaholic, working more than 15 hours a day. Therefore, netizens joked one after another: finally found a "shortcut to longevity" worth emulating.

In fact, Kissinger's longevity can be said to be a "shortcut" compared to other ways of prolonging the lives of the rich, because he has an innate longevity gene. From Warren Buffett to Li Ka-shing, from Bezos, the former richest man, to Altman, the founder of OpenAI, the rich have invested a lot of energy and wealth in the field of slowing down aging, hoping to find a revolutionary technology that can extend their lives. Fortunately, the pursuit of these top billionaires has revealed a scientifically feasible path for us, and Harvard's Schginer NAD+ technology has become one of the most promising life extension technologies of the 21st century.

In 2013, Sinclair, a professor of genetics at Harvard, confirmed for the first time that the level of NAD+ (a molecule that inhibits aging and controls metabolism) in the human body gradually declines as we age. And Schginer's NAD+ lifting technology can rejuvenate the body of an elderly mammal, which is equivalent to extending the human body by 138-year life cycle.

Since then, research has flourished, and thanks to the rigorous research of modern biomedicine, Harvard's aging inhibitor "Schginer" has successfully moved from theory to practice, and many celebrities and dignitaries have rushed to use this mechanism to prolong their own lives.

In 2017, Li Ka-shing, the former richest man in Hong Kong, went to the United States to investigate "Shijiner" technology and invested US$200 million to support research and development to promote the commercialization of longevity. Now, five years later, the 96-year-old Li Ka-shing is still active in the business world, and recently showed affection to his girlfriend Zhou Kaixuan, who is 32 years younger than him.

Industry-related reports show that the cost of Shijina NAD+ was high at first, because the extraction technology was not developed, and the cost per gram was as high as 22,641 yuan, which made ordinary people prohibitive. However, the year after Li Ka-shing went to the United States to inspect investment, Schginer came out as the world's first NAD+ technology product, and Harvard's technology reduced the cost to less than $200 (about 1,000 yuan on JD.com), lowering the threshold by a full 93. Therefore, technology intervention in aging is no longer just the preserve of the rich.

Since Shijiner's entry into the JD.com platform, many people who are trying to extend the life of technology for the first time have publicly shared their experiences of using it. Among the more than 20,000 feedbacks, some people said that "sleep quality has improved", "more energy", etc., all show signs that life is gradually slowing down.

Warren Buffett once said that time and love are the most precious things in this era. According to P&S Intelligence**, the global anti-aging market represented by Schginer's aging intervention technology will reach $421.2 billion by 2030. Obviously, compared with Kissinger's illusory longevity gene, Schjiner has a more down-to-earth scientific research background and celebrity endorsement, which is not difficult to explain why the thousand-yuan Schjiner quickly attracted the attention of hundreds of thousands of high-net-worth individuals after it was launched on JD.com.

Research from Stanford University shows that the average life expectancy gap between the poorest and richest people in the United States is 15 years, and the most critical factor is biomedical interventions. Nowadays, with the rapid development of technology, the Schginer products that intervene in aging have begun to be popularized to more people. Therefore, we have reason to believe that with the explosion of life science technology, longevity is no longer just the privilege of the rich, and we will witness more and more people embark on the glorious road to a century of prosperity.

Related Pages